Indian Infertility Diagnosis and Treatment Market
Indian Infertility Diagnosis and Treatment Market Research and Analysis, 2015-2022
INDIAN INFERTILITY MARKET INSIGHTS:
The Indian infertility market is anticipated to grow with the CAGR of 12.5% during the period 2017-2022. The major factors that are augmenting the growth of the market are increasing geriatric population in India, Rising alcohol and cigarettes consumption in India. Additionally, rising secondary infertility, increasing penetration of infertility clinics in small towns, growing marriageable age, increasing use of contraceptives are also estimated to be major factors that are driving the growth of infertility diagnosis and treatment market in India.
Alcohol consumption in India is one of the major factors responsible for the infertility in the country. Alcohol consumption in India has risen by 55% during the last two decades. Furthermore, young generation age less than 20 are getting initiated to alcohol much earlier, whereas more women are indulging in binge and hazardous drinking. According to WHO, 30% of the India’s population consume alcohol, out of which 4-15% of them are consumes alcohol daily and about 50% of them are under the hazardous drinking category. Alcohol consumption among female can cause irregular periods, irregular ovulation and can reduce the chances of conception. Therefore the increasing alcohol consumption is estimated to augment the demand of infertility treatment in India.
Increasing geriatric population is also one of the major factors driving the growth of the Indian Infertility Market. In the year 2015, population aging 65 year or older is estimated to account for about 6% of the total population of the India i.e. 78 million, it is further estimated to reach 8.8% by the year 2030. Therefore increasing geriatric population are estimated to fuel the growth of the infertility market in India.
However, there are certain factors that are affecting the growth of the infertility diagnosis and treatment market in India. High cost of treatment, low awareness and lack of trust among people, social stigma related to infertility treatment and lack of regulatory framework and rules and regulation to control the market are the major factors that are hindering the growth of the market in the region.
Alcohol consumption in India is one of the major factors responsible for the infertility in the country. Alcohol consumption in India has risen by 55% during the last two decades. Furthermore, young generation age less than 20 are getting initiated to alcohol much earlier, whereas more women are indulging in binge and hazardous drinking. According to WHO, 30% of the India’s population consume alcohol, out of which 4-15% of them are consumes alcohol daily and about 50% of them are under the hazardous drinking category. Alcohol consumption among female can cause irregular periods, irregular ovulation and can reduce the chances of conception. Therefore the increasing alcohol consumption is estimated to augment the demand of infertility treatment in India.
Increasing geriatric population is also one of the major factors driving the growth of the Indian Infertility Market. In the year 2015, population aging 65 year or older is estimated to account for about 6% of the total population of the India i.e. 78 million, it is further estimated to reach 8.8% by the year 2030. Therefore increasing geriatric population are estimated to fuel the growth of the infertility market in India.
However, there are certain factors that are affecting the growth of the infertility diagnosis and treatment market in India. High cost of treatment, low awareness and lack of trust among people, social stigma related to infertility treatment and lack of regulatory framework and rules and regulation to control the market are the major factors that are hindering the growth of the market in the region.
COMPETITIVE INSIGHTS
Key players of the Indian infertility market are Abbott India Limited, Bourn Hall International India Pvt. Ltd., Cadila Healthcare Ltd., Cipla Ltd., Dr. Rama’s Institute for Fertility, GlaxoSmithKline Pharmaceuticals Limited, Moolchand Fertility & IVF, Morpheus Life Sciences Pvt. Ltd., Nova IVI Fertility, Pfizer India, Sun Pharmaceutical Industries Ltd.
OMR Report covers:
• Comprehensive research methodology of Indian Infertility Market
• This report also includes detailed and extensive market overview with Analyst insights & key market trends.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Indian Infertility Market
• Insights about market determinants which are stimulating the Indian Infertility Market
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
• This report also includes detailed and extensive market overview with Analyst insights & key market trends.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Indian Infertility Market
• Insights about market determinants which are stimulating the Indian Infertility Market
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.
0 Comments